This is a preview of subscription content, log in via an institution to check access.
Notes
In case 2, the patient was referred as "woman" in case presentation and referred as "male" in "Table 1". Due to the data discrepancy, the patient's gender was considered as woman based on the case presentation.
Reference
Yoshiji S, et al. Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases. Journal of Diabetes Investigation 9: 445-447, No. 2, Mar 2018. Available from: URL: http://doi.org/10.1111/jdi.12695 - Japan
Rights and permissions
About this article
Cite this article
CD26 antigen inhibitors. Reactions Weekly 1697, 106 (2018). https://doi.org/10.1007/s40278-018-44662-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44662-z